查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1694825

2025年全球原代細胞市場報告

Primary Cells Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年原代細胞的市場規模將快速成長。到 2029 年，這一數字將成長至 24.6 億美元，複合年成長率為 10.1%。預測期內的成長可歸因於個性化醫療需求的不斷成長、對幹細胞研究的日益關注、投資的不斷增加以及基於細胞的檢測方法的日益普及。預測期內的關鍵趨勢包括對人類原代細胞的需求、研究工具和技術的進步以及基於細胞的治療方法的採用。

預計政府對癌症研究的津貼增加將在未來幾年推動原代細胞市場的成長。津貼是指向計劃、舉措、組織或個人提供的財政支持，以使其能夠發展、運作或實現特定目標。在原代細胞研究中，政府資金用於支持研究計劃、人員支援、設備和基礎設施、培訓和教育、法規遵循和技術開發。例如，2022年5月，美國美國癌症研究機構美國癌症研究所（AICR）申請2023年資金490億美元，比前一年的464億美元增加41億美元。因此，預計政府對癌症研究的津貼增加將推動原代細胞市場的成長。

初級細胞市場的主要企業正專注於細胞產品的創新，包括細胞培養和幹細胞產品，以促進研究和治療發展的進步。例如，無血清培養基是一種用於細胞和組織培養的生長培養基，不含動物來源的血清，例如牛(FBS)。 2024年7月，專注於生物技術和生命科學解決方案的印度公司Bioserve Biotechnologies (India) Private Ltd.將REPROCELL先進的幹細胞產品引入印度市場。這些新產品旨在促進科學研究和藥物開發的進步，為該地區再生醫學和治療方法發現的發展做出貢獻。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球原代細胞市場的 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
  • 最終用途產業分析
  • 全球原代細胞市場：成長率分析
  • 全球原代細胞市場表現：規模與成長，2019-2024
  • 全球原代細胞市場預測：規模與成長，2024-2029，2034
  • 全球原發細胞總可尋址市場（TAM）

第6章市場區隔

  • 全球原代細胞市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 造血細胞
  • 皮癬菌
  • 胃腸細胞
  • 肝細胞
  • 肺細胞
  • 腎臟細胞
  • 心臟細胞
  • 肌肉骨骼細胞
  • 其他
  • 全球原代細胞市場（依來源）：績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 人類原代細胞
  • 動物來源的原代細胞
  • 全球原代細胞市場（按最終用戶、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 製藥
  • 生技公司
  • 合約研究組織（CRO）
  • 學術研究所
  • 其他
  • 全球原代細胞市場：造血細胞細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 骨髓來源的細胞
  • 周邊血來源的細胞
  • 全球原代細胞市場：皮癬菌細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 角質形成細胞
  • 纖維母細胞
  • 全球原代細胞市場：胃腸細胞細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 腸上皮細胞
  • 杯狀細胞
  • 潘氏細胞
  • 全球原代細胞市場：肝細胞細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 肝細胞
  • 肝星狀細胞
  • 全球原代細胞市場：肺細胞細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 肺泡上皮細胞
  • 支氣管上皮細胞
  • 全球原代細胞市場：腎細胞細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 近端小管細胞
  • 腎絲球細胞
  • 全球原代細胞市場：心臟細胞細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 心肌細胞
  • 心臟纖維母細胞
  • 全球原代細胞市場：肌肉骨骼細胞細分（按類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 成肌細胞
  • 軟骨細胞
  • 全球原代細胞市場：其他細分市場：按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 內皮細胞
  • 脂肪細胞

第7章 區域和國家分析

  • 全球原代細胞市場各地區表現及預測（2019-2024、2024-2029、2034）
  • 全球原代細胞市場（依國家分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 原代細胞市場：競爭格局
  • 原代細胞市場：公司簡介
    • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Cytiva Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Lonza Group Ltd
  • Charles River Laboratories Inc.
  • STEMCELL Technologies Inc
  • American Type Culture Collection
  • Cell Signaling Technology
  • BioIVT
  • InvivoGen
  • HemaCare Corporation
  • Creative Bioarray Inc.
  • PromoCell GmbH
  • CellGenix
  • AllCells LLC
  • Axol Bioscience Ltd
  • PBS Biotech Inc
  • AnaBios Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年原發性細胞市場：提供新機會的國家
  • 2029年原電池市場：細分市場帶來新機會
  • 2029年原代細胞市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r28802

Primary cells refer to cells extracted directly from the living tissues of animals or people and then treated to prepare them for use in suitable cell treatments. These cells are employed in various applications, including 3D cell cultivation, virology, cancer research, stem cell treatment, and tissue restoration.

The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.

The main types of primary cells are hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and others. Hematopoietic cells are a type of stem cell that gives rise to the various blood cell types in the body. Its origins are human primary cells and animal primary cells, and its end users are pharmaceuticals, biotechnology companies, contract research organizations (CROs), academic and research institutes, and others.

The primary cells market size has grown rapidly in recent years. It will grow from $1.49 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to rising prevalence of cancer, increasing investments in regenerative medicine research, growing demand for monoclonal antibodies, advantages of primary human cells over cell lines, increasing prevalence of chronic diseases.

The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing focus on stem cell research, rising investments, increasing adoption of cell-based assays. Major trends in the forecast period include demand for human primary cells, advancements in research tools and technologies, adoption of cell-based therapies.

The rising government funding for cancer research is expected to propel the growth of the primary cells market going forward. Funding refers to the financial support provided to a project, initiative, organization, or individual to enable its development, operation, or achievement of specific goals. Government funding is used in primary cells to support research projects, personnel support, equipment and infrastructure, training and education, regulatory compliance, and technology development. For instance, in May 2022, the American Institute for Cancer Research (AICR), a US-based large American cancer research organization, requested $49 billion funding in 2023, which is an increase of $4.1 billion compared to the previous year's $46.4 billion. Therefore, rising government funding for cancer research is expected to propel the growth of the primary cell market.

Leading companies in the primary cell market are focusing on innovations in cell products, including cell culture and stem cell products, to drive progress in research and therapeutic development. Serum-free medium, for example, is a type of growth medium for cell or tissue cultures that excludes animal-derived serums, such as fetal bovine serum (FBS). In July 2024, Bioserve Biotechnologies (India) Private Ltd., an Indian company specializing in biotechnology and life sciences solutions, introduced advanced stem cell products from REPROCELL to the Indian market. These new products aim to foster advancements in scientific research and drug development, contributing to growth in regenerative medicine and therapeutic discovery in the region.

In April 2023, AnaBios Corporation, a US-based biotechnology company, acquired Cell Systems for an undisclosed amount. This acquisition was aimed at expanding AnaBios' unique human tissue and cell portfolio, providing enhanced translational tools and reagents to academic, pharmaceutical, and biotech researchers, and optimizing research programs through enhanced human insights. Cell Systems is a US-based biotechnology company that specializes in providing human primary cells and cell culture media.

Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA, BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection, Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc

North America was the largest region in the primary cells market in 2024. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the primary cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary cells market consists of revenues earned by entities by providing services such as cell isolation services, primary cell culture services, cell characterization, and authentication. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell market also includes sales of cell culture media and reagents, cell culture plates and flasks, cell isolation kits, and transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Primary Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on primary cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for primary cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The primary cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Hematopoietic Cells; Dermatophytes; Gastrointestinal Cells; Hepatocytes; Lung Cells; Renal Cells; Heart Cells; Musculoskeletal Cells; Other Primary Cells
  • 2) By Origin: Human Primary Cells; Animal Primary Cells
  • 3) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations (CRO); Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Hematopoietic Cells: Bone Marrow-Derived Cells; Peripheral Blood-Derived Cells
  • 2) By Dermatophytes: Keratinocytes; Fibroblasts
  • 3) By Gastrointestinal Cells: Enterocytes; Goblet Cells; Paneth Cells
  • 4) By Hepatocytes: Liver Parenchymal Cells; Hepatic Stellate Cells
  • 5) By Lung Cells: Alveolar Epithelial Cells; Bronchial Epithelial Cells
  • 6) By Renal Cells: Proximal Tubular Cells; Glomerular Cells
  • 7) By Heart Cells: Cardiomyocytes; Cardiac Fibroblasts
  • 8) By Musculoskeletal Cells: Myoblasts; Chondrocytes
  • 9) By Other Primary Cells: Endothelial Cells; Adipocytes
  • Companies Mentioned: Thermo Fisher Scientific Inc; Merck KGaA; BD Biosciences; Corning Incorporated; Cytiva
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Primary Cells Market Characteristics

3. Primary Cells Market Trends And Strategies

4. Primary Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Primary Cells Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Primary Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Primary Cells Market Growth Rate Analysis
  • 5.4. Global Primary Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Primary Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Primary Cells Total Addressable Market (TAM)

6. Primary Cells Market Segmentation

  • 6.1. Global Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematopoietic Cells
  • Dermatophytes
  • Gastrointestinal Cells
  • Hepatocytes
  • Lung Cells
  • Renal Cells
  • Heart Cells
  • Musculoskeletal Cells
  • Other Primary Cells
  • 6.2. Global Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Primary Cells
  • Animal Primary Cells
  • 6.3. Global Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceuticals
  • Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Academic And Research Institutes
  • Other End Users
  • 6.4. Global Primary Cells Market, Sub-Segmentation Of Hematopoietic Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Marrow-Derived Cells
  • Peripheral Blood-Derived Cells
  • 6.5. Global Primary Cells Market, Sub-Segmentation Of Dermatophytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Keratinocytes
  • Fibroblasts
  • 6.6. Global Primary Cells Market, Sub-Segmentation Of Gastrointestinal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enterocytes
  • Goblet Cells
  • Paneth Cells
  • 6.7. Global Primary Cells Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Parenchymal Cells
  • Hepatic Stellate Cells
  • 6.8. Global Primary Cells Market, Sub-Segmentation Of Lung Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alveolar Epithelial Cells
  • Bronchial Epithelial Cells
  • 6.9. Global Primary Cells Market, Sub-Segmentation Of Renal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proximal Tubular Cells
  • Glomerular Cells
  • 6.10. Global Primary Cells Market, Sub-Segmentation Of Heart Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiomyocytes
  • Cardiac Fibroblasts
  • 6.11. Global Primary Cells Market, Sub-Segmentation Of Musculoskeletal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Myoblasts
  • Chondrocytes
  • 6.12. Global Primary Cells Market, Sub-Segmentation Of Other Primary Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endothelial Cells
  • Adipocytes

7. Primary Cells Market Regional And Country Analysis

  • 7.1. Global Primary Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Primary Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Primary Cells Market

  • 8.1. Asia-Pacific Primary Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Primary Cells Market

  • 9.1. China Primary Cells Market Overview
  • 9.2. China Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Primary Cells Market

  • 10.1. India Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Primary Cells Market

  • 11.1. Japan Primary Cells Market Overview
  • 11.2. Japan Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Primary Cells Market

  • 12.1. Australia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Primary Cells Market

  • 13.1. Indonesia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Primary Cells Market

  • 14.1. South Korea Primary Cells Market Overview
  • 14.2. South Korea Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Primary Cells Market

  • 15.1. Western Europe Primary Cells Market Overview
  • 15.2. Western Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Primary Cells Market

  • 16.1. UK Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Primary Cells Market

  • 17.1. Germany Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Primary Cells Market

  • 18.1. France Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Primary Cells Market

  • 19.1. Italy Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Primary Cells Market

  • 20.1. Spain Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Primary Cells Market

  • 21.1. Eastern Europe Primary Cells Market Overview
  • 21.2. Eastern Europe Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Primary Cells Market

  • 22.1. Russia Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Primary Cells Market

  • 23.1. North America Primary Cells Market Overview
  • 23.2. North America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Primary Cells Market

  • 24.1. USA Primary Cells Market Overview
  • 24.2. USA Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Primary Cells Market

  • 25.1. Canada Primary Cells Market Overview
  • 25.2. Canada Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Primary Cells Market

  • 26.1. South America Primary Cells Market Overview
  • 26.2. South America Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Primary Cells Market

  • 27.1. Brazil Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Primary Cells Market

  • 28.1. Middle East Primary Cells Market Overview
  • 28.2. Middle East Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Primary Cells Market

  • 29.1. Africa Primary Cells Market Overview
  • 29.2. Africa Primary Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Primary Cells Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Primary Cells Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Primary Cells Market Competitive Landscape And Company Profiles

  • 30.1. Primary Cells Market Competitive Landscape
  • 30.2. Primary Cells Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BD Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cytiva Overview, Products and Services, Strategy and Financial Analysis

31. Primary Cells Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd
  • 31.2. Charles River Laboratories Inc.
  • 31.3. STEMCELL Technologies Inc
  • 31.4. American Type Culture Collection
  • 31.5. Cell Signaling Technology
  • 31.6. BioIVT
  • 31.7. InvivoGen
  • 31.8. HemaCare Corporation
  • 31.9. Creative Bioarray Inc.
  • 31.10. PromoCell GmbH
  • 31.11. CellGenix
  • 31.12. AllCells LLC
  • 31.13. Axol Bioscience Ltd
  • 31.14. PBS Biotech Inc
  • 31.15. AnaBios Corporation

32. Global Primary Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Primary Cells Market

34. Recent Developments In The Primary Cells Market

35. Primary Cells Market High Potential Countries, Segments and Strategies

  • 35.1 Primary Cells Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Primary Cells Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Primary Cells Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer